跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
乐瑞卡 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pregabalin Capsules
Approved
化学药品
Pregabalin Capsules
Upjohn EESV
🇨🇳 National Medical Products Administration
Approval Date
Apr 29, 2020
Approval ID
7MazXbuZDV5
Company
Upjohn EESV
Type
化学药品
Approval Details
Approval Id
7MazXbuZDV5
Approval Number
H20150619
Generic Name
普瑞巴林胶囊
Generic Name En
Pregabalin Capsules
Trade Name
乐瑞卡
Brand Name
乐瑞卡
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
75mg
Reg Date
2020-04-29
Expired Date
2025-04-28
Company Name
Upjohn EESV
Company Address
Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, The Netherlands
Production Company Name
Pfizer Manufacturing Deutschland GmbH
Production Company Address
Betriebsstatte Freiburg, Mooswaldallee 1, D-79090 Freiburg, Germany
Company Detail Path
/organization/upjohn-eesv
Production Company Detail Path
/organization/pfizer-manufacturing-deutschland-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 29, 2020
Approval ID
7MazXbuZDV5
Type
化学药品
Back to NMPA Approvals